Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4211117 | Respiratory Medicine | 2010 | 4 Pages |
Abstract
SummaryWe evaluated the accuracy of a point-of-care test designed to measure adherence to isoniazid (INH) preventive therapy in a hospital setting in Rio de Janeiro, Brazil. Patients on treatment with daily INH and patients not receiving INH were included. Sensitivity and specificity of the test were 84%/98% at the first minute, and 95%/98% at the fifth minute, respectively. Among smokers, sensitivity and specificity was reduced (80%/89% at the fifth minute, respectively), but only 17% smoked. This test accurately detected INH metabolites 24 h following directly observed INH intake, though sensitivity and specificity may be compromised by tobacco smoke exposure.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Renata L. Guerra, Marcus B. Conde, Anne Efron, Carla Loredo, Gisele Bastos, Richard E. Chaisson, Jonathan E. Golub,